BMRN : BioMarin Pharmaceutical stock forecast, predictions, and share price target for 2022, 2023 (1 year) to 2025 - 2027 (5 year) to 2030, and 2032 (10 year) with Revenue and EPS Prognosis by Technical Analysis
| year | Average | Low | High | Change from close on 2022-07-01 |
|---|---|---|---|---|
| 2022 | $83.12 | $81.04 | $84.66 | -2.19% |
| 2023 | $75.5 | $68.77 | $79.91 | -11.15% |
| 2024 | $66.02 | $65.19 | $67.57 | -22.31% |
| 2025 | $100.72 | $68.61 | $150.81 | 18.52% |
| 2026 | $176.64 | $159.18 | $183.82 | 107.86% |
| 2027 | $193.96 | $181.65 | $219.74 | 128.24% |
| 2028 | $236.68 | $220.41 | $248.69 | 178.51% |
| 2029 | $228.24 | $218.72 | $248.0 | 168.58% |
| 2030 | $205.04 | $192.22 | $217.36 | 141.28% |
| 2031 | $179.58 | $172.74 | $192.73 | 111.32% |
| 2032 | $184.6 | $181.71 | $186.48 | 117.22% |
The 5 Wall Street analysts offering BioMarin Pharmaceutical stock forecast in the last 6 months have average price target of
$102.0 with a high forecast of $125.0 and a low forecast of $70.0.
The average BioMarin Pharmaceutical stock forecast represents a 20.03%
increase from the last price of $84.9800033569336.
From AI system, total return is 3084.96% from 3788 forecasts.
For BioMarin Pharmaceutical stock forecast for 2022, 5 predictions are offered for each month of 2022 with average BioMarin Pharmaceutical stock
forecast of $83.12, a high forecast of $84.66, and a low forecast of $81.04.
The average BioMarin Pharmaceutical stock forecast 2022 represents a -2.19%
decrease from the last price of $84.9800033569336.
For BioMarin Pharmaceutical stock forecast for 2023, 12 predictions are offered for each month of 2023 with average BioMarin Pharmaceutical stock
forecast of $75.5, a high forecast of $79.91, and a low forecast of $68.77.
The average BioMarin Pharmaceutical stock forecast 2023 represents a -11.15%
decrease from the last price of $84.9800033569336.
For BioMarin Pharmaceutical stock forecast for 2025, 12 predictions are offered for each month of 2025 with average BioMarin Pharmaceutical stock
forecast of $100.72, a high forecast of $150.81, and a low forecast of $68.61.
The average BioMarin Pharmaceutical stock forecast 2025 represents a 18.52%
increase from the last price of $84.9800033569336.
For BioMarin Pharmaceutical stock forecast for 2027 (5 year), 12 predictions are offered for each month of 2027 with average BioMarin Pharmaceutical stock
forecast of $193.96, a high forecast of $219.74, and a low forecast of $181.65.
The average BioMarin Pharmaceutical stock forecast 2027 represents a 128.24%
increase from the last price of $84.9800033569336.
For BioMarin Pharmaceutical stock forecast for 2030, 12 predictions are offered for each month of 2030 with average BioMarin Pharmaceutical stock
forecast of $205.04, a high forecast of $217.36, and a low forecast of $192.22.
The average BioMarin Pharmaceutical stock forecast 2030 represents a 141.28%
increase from the last price of $84.9800033569336.
For BioMarin Pharmaceutical stock forecast for 2032 (10 year), 7 predictions are offered for each month of 2032 with average BioMarin Pharmaceutical stock
forecast of $184.6, a high forecast of $186.48, and a low forecast of $181.71.
The average BioMarin Pharmaceutical stock forecast 2032 represents a 117.22%
increase from the last price of $84.9800033569336.
Please, see more forecasts below.
BMRN : BioMarin Pharmaceutical stock forecast by Wall Street Analysts
The average BioMarin Pharmaceutical stock forecast from last 6 month is $102.0, and this show a 6.8% increase in average from the prior price target of the each prediction. Also, this average forecast of $102.0 represents a -0.97% decrease from the past average forecast of $103.0, 6 months ago from 6 wall street analysts.
BioMarin Pharmaceutical stock forecast for upcoming days
| Date | Price Target | Change |
|---|---|---|
| 2022-07-04 | $86.68 | 2.00% |
| 2022-07-05 | $90.60 | 4.52% |
| 2022-07-06 | $91.79 | 1.31% |
| 2022-07-07 | $93.26 | 1.60% |
| 2022-07-08 | $93.50 | 0.26% |
BMRN : Long term BioMarin Pharmaceutical stock forecast for 2022, 2023 (1 year) - 2025 - 2027 (5 year) - 2030, and 2032 (10 year)
Forecast for 2022 Aug. is $84.66 , for 2023 Jul. is $76.11 , for 2026 Jul. is $180.19 , for 2027 Jul. is $187.66 , for 2031 Jul. is $172.74 , and for 2032 Jul. is $184.22.
BMRN : BioMarin Pharmaceutical stock forecast for 2022
| Date | Price Target | Change |
|---|---|---|
| 2022 Aug. | $84.66 | -0.37% |
| 2022 Sep. | $84.14 | -0.61% |
| 2022 Oct. | $83.42 | -0.85% |
| 2022 Nov. | $82.32 | -1.32% |
| 2022 Dec. | $81.04 | -1.56% |
BMRN : BioMarin Pharmaceutical stock forecast for 2023
| Date | Price Target | Change |
|---|---|---|
| 2023 Jan. | $79.91 | -1.39% |
| 2023 Feb. | $79.60 | -0.38% |
| 2023 Mar. | $79.20 | -0.51% |
| 2023 Apr. | $78.29 | -1.14% |
| 2023 May. | $77.39 | -1.16% |
| 2023 Jun. | $76.99 | -0.51% |
| 2023 Jul. | $76.11 | -1.15% |
| 2023 Aug. | $74.79 | -1.73% |
| 2023 Sep. | $73.18 | -2.15% |
| 2023 Oct. | $71.69 | -2.04% |
| 2023 Nov. | $70.13 | -2.17% |
| 2023 Dec. | $68.77 | -1.95% |
BMRN : BioMarin Pharmaceutical stock forecast for 2024
| Date | Price Target | Change |
|---|---|---|
| 2024 Jan. | $67.57 | -1.74% |
| 2024 Feb. | $66.58 | -1.46% |
| 2024 Mar. | $65.77 | -1.22% |
| 2024 Apr. | $65.48 | -0.44% |
| 2024 May. | $65.28 | -0.32% |
| 2024 Jun. | $65.21 | -0.10% |
| 2024 Jul. | $65.19 | -0.03% |
| 2024 Aug. | $65.31 | 0.19% |
| 2024 Sep. | $65.68 | 0.56% |
| 2024 Oct. | $66.01 | 0.52% |
| 2024 Nov. | $66.64 | 0.95% |
| 2024 Dec. | $67.48 | 1.25% |
BMRN : BioMarin Pharmaceutical stock forecast for 2025
| Date | Price Target | Change |
|---|---|---|
| 2025 Jan. | $68.61 | 1.68% |
| 2025 Feb. | $70.43 | 2.65% |
| 2025 Mar. | $73.11 | 3.80% |
| 2025 Apr. | $76.99 | 5.31% |
| 2025 May. | $82.50 | 7.15% |
| 2025 Jun. | $89.70 | 8.73% |
| 2025 Jul. | $98.44 | 9.75% |
| 2025 Aug. | $108.32 | 10.03% |
| 2025 Sep. | $118.92 | 9.79% |
| 2025 Oct. | $129.95 | 9.27% |
| 2025 Nov. | $140.83 | 8.37% |
| 2025 Dec. | $150.81 | 7.09% |
BMRN : BioMarin Pharmaceutical stock forecast for 2026
| Date | Price Target | Change |
|---|---|---|
| 2026 Jan. | $159.18 | 5.55% |
| 2026 Feb. | $165.77 | 4.14% |
| 2026 Mar. | $170.63 | 2.93% |
| 2026 Apr. | $174.13 | 2.05% |
| 2026 May. | $176.68 | 1.46% |
| 2026 Jun. | $178.64 | 1.10% |
| 2026 Jul. | $180.19 | 0.87% |
| 2026 Aug. | $181.43 | 0.69% |
| 2026 Sep. | $182.39 | 0.53% |
| 2026 Oct. | $183.13 | 0.40% |
| 2026 Nov. | $183.63 | 0.27% |
| 2026 Dec. | $183.82 | 0.11% |
BMRN : BioMarin Pharmaceutical stock forecast for 2027
| Date | Price Target | Change |
|---|---|---|
| 2027 Jan. | $183.65 | -0.09% |
| 2027 Feb. | $183.09 | -0.31% |
| 2027 Mar. | $182.29 | -0.44% |
| 2027 Apr. | $181.65 | -0.35% |
| 2027 May. | $181.85 | 0.11% |
| 2027 Jun. | $183.64 | 0.99% |
| 2027 Jul. | $187.66 | 2.19% |
| 2027 Aug. | $194.01 | 3.39% |
| 2027 Sep. | $202.14 | 4.19% |
| 2027 Oct. | $210.62 | 4.19% |
| 2027 Nov. | $217.15 | 3.10% |
| 2027 Dec. | $219.74 | 1.19% |
BMRN : BioMarin Pharmaceutical stock forecast for 2028
| Date | Price Target | Change |
|---|---|---|
| 2028 Jan. | $220.41 | 0.31% |
| 2028 Feb. | $222.86 | 1.11% |
| 2028 Mar. | $226.46 | 1.62% |
| 2028 Apr. | $229.86 | 1.50% |
| 2028 May. | $232.60 | 1.19% |
| 2028 Jun. | $235.10 | 1.07% |
| 2028 Jul. | $238.48 | 1.44% |
| 2028 Aug. | $242.68 | 1.76% |
| 2028 Sep. | $246.24 | 1.47% |
| 2028 Oct. | $248.06 | 0.74% |
| 2028 Nov. | $248.66 | 0.24% |
| 2028 Dec. | $248.69 | 0.01% |
BMRN : BioMarin Pharmaceutical stock forecast for 2029
| Date | Price Target | Change |
|---|---|---|
| 2029 Jan. | $248.00 | -0.28% |
| 2029 Feb. | $244.85 | -1.27% |
| 2029 Mar. | $236.35 | -3.47% |
| 2029 Apr. | $229.01 | -3.11% |
| 2029 May. | $226.24 | -1.21% |
| 2029 Jun. | $224.92 | -0.58% |
| 2029 Jul. | $224.01 | -0.40% |
| 2029 Aug. | $223.20 | -0.36% |
| 2029 Sep. | $222.31 | -0.40% |
| 2029 Oct. | $221.26 | -0.48% |
| 2029 Nov. | $220.01 | -0.57% |
| 2029 Dec. | $218.72 | -0.59% |
BMRN : BioMarin Pharmaceutical stock forecast for 2030
| Date | Price Target | Change |
|---|---|---|
| 2030 Jan. | $217.36 | -0.62% |
| 2030 Feb. | $215.58 | -0.82% |
| 2030 Mar. | $213.38 | -1.02% |
| 2030 Apr. | $210.93 | -1.15% |
| 2030 May. | $208.38 | -1.21% |
| 2030 Jun. | $205.91 | -1.19% |
| 2030 Jul. | $203.61 | -1.12% |
| 2030 Aug. | $201.50 | -1.03% |
| 2030 Sep. | $199.52 | -0.99% |
| 2030 Oct. | $197.36 | -1.08% |
| 2030 Nov. | $194.68 | -1.36% |
| 2030 Dec. | $192.22 | -1.26% |
BMRN : BioMarin Pharmaceutical stock forecast for 2031
| Date | Price Target | Change |
|---|---|---|
| 2031 Jan. | $192.73 | 0.26% |
| 2031 Feb. | $191.27 | -0.76% |
| 2031 Mar. | $186.04 | -2.74% |
| 2031 Apr. | $179.56 | -3.48% |
| 2031 May. | $174.85 | -2.63% |
| 2031 Jun. | $172.77 | -1.19% |
| 2031 Jul. | $172.74 | -0.02% |
| 2031 Aug. | $173.78 | 0.60% |
| 2031 Sep. | $175.29 | 0.87% |
| 2031 Oct. | $177.03 | 0.99% |
| 2031 Nov. | $178.70 | 0.94% |
| 2031 Dec. | $180.25 | 0.87% |
BMRN : BioMarin Pharmaceutical stock forecast for 2032
| Date | Price Target | Change |
|---|---|---|
| 2032 Jan. | $181.71 | 0.81% |
| 2032 Feb. | $183.14 | 0.78% |
| 2032 Mar. | $184.48 | 0.74% |
| 2032 Apr. | $185.67 | 0.64% |
| 2032 May. | $186.48 | 0.44% |
| 2032 Jun. | $186.48 | -0.00% |
| 2032 Jul. | $184.22 | -1.21% |
Financial Data for BioMarin Pharmaceutical stock
Frequently Asked Questions about BioMarin Pharmaceutical stock forecast
Is BioMarin Pharmaceutical a good long term stock?
From BioMarin Pharmaceutical stock forecast , BioMarin Pharmaceutical (BMRN) stock cannot be a good investment choice. According to AI Pickup, the BioMarin Pharmaceutical stock price forecast for 2022 Aug. is $84.6636726152584 From BioMarin Pharmaceutical stock forecast , BioMarin Pharmaceutical (BMRN) stock cannot be a good investment choice. According to AI Pickup, the BioMarin Pharmaceutical stock price forecast for 2023 Jul. is $76.1059051089427 From BioMarin Pharmaceutical stock forecast , BioMarin Pharmaceutical (BMRN) stock can be a good investment choice. According to AI Pickup, the BioMarin Pharmaceutical stock price forecast for 2026 Jul. is $180.186598197768 From BioMarin Pharmaceutical stock forecast , BioMarin Pharmaceutical (BMRN) stock can be a good investment choice. According to AI Pickup, the BioMarin Pharmaceutical stock price forecast for 2027 Jul. is $187.65655256857 From BioMarin Pharmaceutical stock forecast , BioMarin Pharmaceutical (BMRN) stock can be a good investment choice. According to AI Pickup, the BioMarin Pharmaceutical stock price forecast for 2031 Jul. is $172.739015305331 From BioMarin Pharmaceutical stock forecast , BioMarin Pharmaceutical (BMRN) stock can be a good investment choice. According to AI Pickup, the BioMarin Pharmaceutical stock price forecast for 2032 Jul. is $184.220332739865
Is BioMarin Pharmaceutical stock overvalued?
BioMarin Pharmaceutical (BMRN) stock is expected to go DOWN . Therefore, AI Pickup would say that BioMarin Pharmaceutical (BMRN) stock is overvalued.
Will BioMarin Pharmaceutical stock price go up?
No. The BioMarin Pharmaceutical stock price forecast for 2023 Jul. is $76.1059051089427
Is BioMarin Pharmaceutical stock a good buy now?
Since closing price on 2022-07-01 is $84.9800033569336 and forecast for 2023 Jul. is $76.11, BioMarin Pharmaceutical stock is not a good 1 year investment.